Hydroxychloroquine safety and potential efficacy as an antiviral prophylaxis in light of potential wide-spread use in COVID-19: a multinational, large-scale network cohort and self-controlled case series studyFirst published 03/04/2020 Last updated 30/01/2025 EU PAS number: EUPAS34497StudyFinalised